Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Clin Cancer Res. 2022 Sep 1;28(17):3761–3769. doi: 10.1158/1078-0432.CCR-22-0445

Table 2:

Performarvce of model 1 and model 2 In Validation set of Esophageal brushings

Common core set of samples Model 1 Model 2

# samples Up10 Up35-1 Cg6522 YPEL3 Up10+ Up35-1 + Cg522+ YPEL3 Prob_Cg6522+POU3F1
Cutoff 0.01 0.01 40 2.5 Cutoffs as for individual markers 0.45

%Specificity SQ’s (95% Cl) 27 100.0 100.0 100.0 96.3(89.0–100.6) 96.3 (89.0–100.0) 92.6(82.3–100.0)

%Specificity BE (95% Cl) 37 91 9(82.3–100.0) 83.8(70.8–96.8) 100 0(91.0–100.0) 91.9(82.7–100.0) 67.6(49.2–85.9) 83.8(70.8–96.8)

%Sens LGD (95% Cl) 10 10.0 (0–70.0) 30.0(0–80.0) 10.0(0–68.8) 10.0(0–68.0) 50(6.2–93.8) 40.(0–88.0)

%Sens HGD (95% Cl) 15 27.0(0–67.0) 60.0(28.0–92.0) 20.0(0–65.3) 13.0(0–59.9) 80(57.4–100.0) 67(37.9–96.1)

%Sens Early EAC (95% Cl) 12 60.0(11 9–100.0) 60.0(11.9–100.0) 20.0(0–47.7) 20.0(0–47.7) 70.0(18.1–100) 80.0(24.6–100.0)

%Sens EAC (95% Cl) 40 52.5(31 1–73.9) 40.0(16.0–64.0) 45.0(22.0–68.0) 35.0(10.0–60.0) 82.5(61.0–100.0) 82.5(69.5–95.5)